Azitra, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US05479L1044
USD
0.37
-0.01 (-1.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

173.34 k

Shareholding (Mar 2025)

FII

1.17%

Held by 3 FIIs

DII

97.95%

Held by 1 DIIs

Promoter

0.01%

How big is Azitra, Inc.?

22-Jun-2025

As of Jun 18, Azitra, Inc. has a market capitalization of 3.95 million, with net sales of 0.01 million and a net profit of -9.10 million over the latest four quarters. The balance sheet shows shareholder's funds of 5.70 million and total assets of 7.36 million.

As of Jun 18, Azitra, Inc. has a market capitalization of 3.95 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.01 million for the latest four quarters, while the net profit for the same period was -9.10 million.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 5.70 million and total assets of 7.36 million.

Read More

What does Azitra, Inc. do?

22-Jun-2025

Azitra, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $3.95 million. Key metrics include a negative P/E ratio, a debt equity of -0.67, and a return on equity of -249.03%.

Overview: <BR>Azitra, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -3 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 3.95 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.67 <BR>Return on Equity: -249.03% <BR>Price to Book: 0.90<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Azitra, Inc. technically bullish or bearish?

20-Sep-2025

As of September 5, 2025, Azitra, Inc. shows a mildly bullish trend according to the weekly MACD, despite bearish signals from daily moving averages and Bollinger Bands, and a significant year-to-date underperformance of -72.44% compared to the S&P 500's 12.22%.

As of 5 September 2025, the technical trend for Azitra, Inc. has changed from mildly bearish to mildly bullish. The weekly MACD indicates a mildly bullish stance, while the daily moving averages and Bollinger Bands are bearish. The RSI shows no signal on both weekly and monthly time frames, and there are no trends indicated by Dow Theory or OBV. <BR><BR>Despite the recent shift to a mildly bullish trend, Azitra has underperformed significantly compared to the S&P 500, with a year-to-date return of -72.44% versus the S&P's 12.22%. Overall, the current technical stance is mildly bullish, but the strength is tempered by bearish signals in other indicators.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 4 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.33

stock-summary
Return on Equity

-503.77%

stock-summary
Price to Book

1.93

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-3 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-58.45%
0%
-58.45%
6 Months
-80.38%
0%
-80.38%
1 Year
-88.92%
0%
-88.92%
2 Years
-99.82%
0%
-99.82%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Azitra, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-3.50%
EBIT Growth (5y)
-5.02%
EBIT to Interest (avg)
-10.07
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.10
Tax Ratio
0.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.49%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.93
EV to EBIT
-0.10
EV to EBITDA
-0.11
EV to Capital Employed
0.80
EV to Sales
1.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-764.52%
ROE (Latest)
-249.03%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 2 Schemes (0.87%)

Foreign Institutions

Held by 3 Foreign Institutions (1.17%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -11.54% vs 40.91% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.80",
          "val2": "-2.50",
          "chgp": "-12.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.90",
          "val2": "-2.60",
          "chgp": "-11.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-354,704.00%",
          "chgp": "35,470.40%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -100.00% vs 133.33% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.35% vs -5.61% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.70",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-10.10",
          "val2": "-6.80",
          "chgp": "-48.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.50",
          "val2": "-3.90",
          "chgp": "138.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.00",
          "val2": "-11.30",
          "chgp": "20.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,405,646.30%",
          "val2": "-10,590.40%",
          "chgp": "-1,39,505.59%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-2.80
-2.50
-12.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.90
-2.60
-11.54%
Operating Profit Margin (Excl OI)
0.00%
-354,704.00%
35,470.40%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -11.54% vs 40.91% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.70
-100.00%
Operating Profit (PBDIT) excl Other Income
-10.10
-6.80
-48.53%
Interest
0.00
0.20
-100.00%
Exceptional Items
1.50
-3.90
138.46%
Consolidate Net Profit
-9.00
-11.30
20.35%
Operating Profit Margin (Excl OI)
-1,405,646.30%
-10,590.40%
-1,39,505.59%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -100.00% vs 133.33% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 20.35% vs -5.61% in Dec 2023

stock-summaryCompany CV
About Azitra, Inc. stock-summary
stock-summary
Azitra, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available